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 Breast cancer is reported to rank fifth among all types of cancer with a case 
of death of 6.6%. In the Central Kalimantan region, early examinations of 
cancers including breast cancer were carried out and 247 tumors in the 
breast were identified (1.76%). Kelakai (Stenochlaena palustris) as one of 
the typical plants of Kalimantan which contain natural chemical 
constituents has been reported to be effective as an anti-inflammatory and 
antioxidant, so that with this potential can be developed to overcome 
diseases associated with it, one of them is breast cancer. This study aimed 
to examine the cytotoxicity of MCF-7 breast cancer cells using ethanol 
extract. Identification of chemical constituent by the qualitative method 
using color reagents. The cytotoxicity assay of kelakai extract against MCF-
7 cells conducted in vitro by the MTT reduction method. The variation of 
concentration used is 1000; 500; 250; 125; 62.5; 31.5; and 15.625 µg/ml, 
doxorubicin as a positive control was performed in a concentration of 1 μg 
/ ml. The results of the cytotoxicity assay showed that the kelakai extract 
had a toxic effect on MCF-7 cells with an IC50 value of 493.57 µg / ml. 
I. Introduction 
Cancer itself has been a serious problem in 
developed country as well as developing country. 
Cancer incidence has decreased in 2018 reached 9.6 
million cases, with 8.8 million cases cause death. 
Breast cancer was reported occupy the fifth order 
among all types of cancer with death cases as many 
as 627000 (6.6%). It increases compare to previous 
data stated that breast cancer occupy the sixth order 
(WHO, 2018). In Centre Borneo, it has been 
conducted early assessment to cancer particularly 
cervical and breast cancer. Tests conducted in 
women aged 30 – 50 years old in 2017 known as 
tumor/bump in breast as many as 247 patients 
(1.76%). This score is more abundant than last year 
in 2016 as many as 82 patients (Dinas Kesehatan, 
2018). 
Kalimantan is an island in Indonesia which 
is known with its biodiversity. Besides, knowledge 
about traditional medicine has been passing down 
from one generation to other generation in 
Kalimantan native ethnicity (Fahruni, et al., 2018). 
One of the typical plants of Kalimantan which has a 
specific history as traditional medicine is kelakai. 
Kelakai is very commonly consumed by the 
community and easily to find around the house. 
Kelakai has been reported to be effective for treating 
anti-inflammatory. The alkaloid content can inhibit 
prostaglandin synthesis and steroid content can 
inhibit the activity of phospholipase and change 
arachidonic acid into prostaglandin, and inhibit 
cytokine production. In other studies, Kelakai is 
reported potent to TNF-α levels thus can be 
developed as an anti-malaria drug (Margono et al., 
2016). 
The Dayak tribes believe that by 
consuming the leaves of kelakai, they can treat 
various diseases and for breastfeeding mother the 
leaves of kelakai is believed to increase and expedite 
the production of breast milk. This is related to the 
efficacy in fulfilling Fe in nursing mothers and 
toddlers (Indrayanti et al., 2016). Breastfeeding can 
be one way that prevent breast cancer because 
during breastfeeding there are hormonal changes, 
one of which is a decrease in the hormone estrogen. 
Estrogen is one of the triggers for breast cancer.    At 
the time of breastfeeding progesterone will be more 
dominant than the hormone estrogen, thus women 
can avoid breast cancer. 
Based on that, it should be conducted 
scientific assay to prove cytotoxicity of Kelakai to 
breast cell cancer MCF 7. The aim of this research 
is to become a novel new breast cancer medication 
which can be developed as a traditional breast cancer 
medicine or active compound isolation which can be 
a choice of chemotherapy, as well as scientific basis 
data for further research. 
 
II. Research Method 
II.1 Material 
Materials used in this research is Kelakai, 
DMSO, ethanol 96%, blue tip, yellow tip,Media 
RPMI, MTT reagent, MCF-7 cell cancer, 
Doxorubicin, 96 wellplate. 
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II.2 Tools 
Tools applied are maseration package, 
stirring rod, extract, measuring glass, test tube, 
chemical glass, micropipette, tweezers, bath, spoit, 
incubator, ependorf tube, rotavapor, analytical 
measurement, pipette, microplate reader. 
II.3 Extraction 
Powdered plants were extracted by 
maceration method using 96% ethanol liquid. Initial 
maceration uses 96% ethanol with comparison 
between sample and solution 1: 4 for 3 days. The 
filtered solution is collected and then the solution is 
re-macerated again with similar liquid. The results 
of the storage are collected and then evaporated with 
a rotary evaporator until the extract is obtained. 
II.4 Cytotoxicity Assay 
1. Extract and Control Sample Preparation 
The kelakai plant extract is prepared with a 
final concentration of 1000; 500; 250; 125; 62.5; 
31.5; and 15.625 µg / ml. The positive control 
applied in this study was doxorubicin at the final 
concentration of 1 µg / ml. 
2. Activity Assay 
Cytotoxicity assay of MCF-7 breast cancer 
cells was performed using the MTT method in 
accordance with the modified Graidist (2015) 
method. MCF-7 breast cancer cells were incubated 
in 96 wellplates for 24 hours. After that the extract 
and control were added and incubated for 72 hours. 
After that the cells were isolated with 1X PBS liquid 
and incubated with 100 µl of 0.5 mg / ml MTT at 
37°C. After 30 minutes, 100 µl of the MDO stopper 
reagent was added to each wellplate. Absorbance 
was measured at a wavelength of 550 nm using a 
microplate reader. The absorbance value obtained is 
used for the percentage of cell viability calculated by 
the formula: 
% Viability =   
Cell absorbance with treatment-  absorbance of blank sample
Absorbance of control celll – absorbance of blank sample
       (1) 
II.5 Result analysist 
The data obtained was tabulated and 
analyzed using Microsoft Office Excel 2013. The 
results obtained were translated into the average 
percent cell viability and standard deviation (SD). 
After that, the IC50 determination of the plant 
extracts was applied. 
III. Result and Discussion 
III.1 Sample preparation 
The sample used in this study was a plant 
that was obtained in Palangka Raya City (Figure 1). 
The sample used is dried first, after it is dried and 
then powdered.  The sample powder obtained was 














Figure 1. Kelakai 
Extraction is the process of separating 
compounds from plant parts using selective solvents 
through standard procedures. The aim is to separate 
dissolved plant metabolites from insoluble residues. 
During the extraction process, the solvent will 
diffuse into the solid material and dissolve the 
compound with similar polarity. One of the most 
commonly used extraction methods is maceration. 
Maceration is the simplest extraction technique 
which is conducted by immersing plant material (in 
the rough or powder form) in a container using 
solvent and left at room temperature for at least 3 
days while occasionally stirring. This process is 
intended to soften and break the plant cell walls to 
release soluble compounds so that more extraction 
results can be obtained (Nn, 2015; Tiwari et al., 
2011). 
The solvent used in this extraction process 
is 96% ethanol. Ethanol is used as a universal 
solvent because it is easy to dissolve active 
compounds both polar, semi-polar and non-polar. In 
addition, ethanol easily penetrates into plant cells. A 
total of 1165 g of powdered Kelakai was extracted 
and 25 g of extract was obtained. The yield values 
obtained are shown in table 1. 
Rendamen calculation =
the weight of extract
the weight of powdered  
x 100%   (2) 
 
Table 1. Rendamen value of Kelakai 
Sample Rendemen (%) 
Kelakai Extract 1.72 
Extract rendamen was calculated to simplisia 
powder. 
III.2 Cytotoxicity Assay to Breast Cancer Cell 
MCF-7 
MCF-7 cells are human breast 
adenocarcinoma cells which endogenously express 
estrogen receptor (ER) α mainly and also some ER 
β (Dagher et al., 2012; Vantangoli et al., 2015). 
MCF-7 cells are estrogen responsive, and are often 
used in vitro to study estrogen receptors for positive 
breast cancer. The popularity of MCF-7 is largely 
due to its extraordinary hormone sensitivity through 
the expression of estrogen receptors (ER) (Holliday 
and Speirs, 2011; Vantangoli et al., 2015). In 
addition to expressing estrogen receptors, MCF-7 
cells also express androgen, progesterone, and 
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glucocorticoid receptors. As a targeted agent for all 
steroid signaling pathways, these cells are also 
active for testing against metastatic breast cancer. 
The cytotoxicity test of the user extracts against 






























Figure 2. MCF-7 Cell growth: (a) Before treatment; (b) After treatment with kelakai extract; and (c) after 
treatment with doxorubicin 
MTT testing is an appropriate and sensitive 
technique for measuring cell cytotoxicity. This 
method can be applied for testing cytotoxicity, cell 
viability, and proliferation in cell biology based on 
the reduction of tetrazolium salts through 
dehydrogena sesucinate mitochondria in cells 
(Houdkova et al., 2017; Stockert et al., 2012; Yang 
et al., 2015). Measurement of cell viability plays an 
important role in toxicity assay (Xu et al., 2015). 
The condition of MCF-7 cells after 
treatment with the extract is shown in Figure 2b. 
When compared with the condition of the cells 
before treatment (Figure 2a), there will be seen 
many cells that are not intact or die after treatment 
with the extract. Percentage of MCF-7 cell viability 
decreased with increasing concentration of the 
extracts used and there was a difference between the 
various variations of the concentration used, 15.625; 
31.5; 62.5; 125; 250; 500 and 1000 µg / ml (Figure 
2). Various variations of these concentrations, 
respectively, revealed a value of percent viability 
that is 98.27 ± 7.92; 78.65 ± 3.83%; 80.69 ± 3.12%; 
79.91 ± 0.59%; 73.72 ± 0.94%; 51.40 ± 0.37% and 
7.24 ± 1.12% (IC50: 493.57 µg / ml). IC50 values 
obtained> 200 µg / ml indicate that the sample 
activity was very weak (Bahriul et al, 2014). On the 
other hand, the doxorubicin percent viability 
concentration of 1 μg / ml was 0.82 ± 0.38% and 















Figure 2. %viability cell of Kelakai extract in 
various concentration with positive control of 
Doxorubicin (average ± SD, n = 3) 
 According to Adawiyah and Rizki (2018) 
the antioxidant activity of Kalakai root extract was 
assayed  using the Inhibitory Concentration 50 (IC50) 
parameter with DPPH (2,2-Diphenyl-1-
Pikrilhidrazil) method having a very strong 
antioxidant activity with an IC50 value of 19.06 µg / 
ml. Isolation fraction of ethanol extract and ethyl 
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highest cytotoxicity effect on HeLa cells and the 
highest free radical inhibitory activity. IC50 values 
were 4.58 μg / ml and 8.60 μg / ml, respectively, and 
the value of free radical inhibition activity was 98.47 
± 0.002% (ED50 = 0.120 mg / mL) and 81.38 ± 
0.018% (ED50 = 0.650 mg / mL) (Arullappan et al., 
2017). If the IC50 value obtained <50 µg / ml 
indicates that the sample activity is categorized as 
very strong (Bahriul et al, 2014) 
The bioactive content of the sample is a 
major factor in potential cytotoxicity and antioxidant 
agents. Flavonoids have been proven to be a 
therapeutic agent compound for preventing cancer 
by their mechanism of action decreasing cancer cell 
proliferation and significantly reducing the 
expression of angiogenesis, vascular endothelial 
growth factor (VEGF), in ovarian cancer cells. 
Flavonoids have also been shown to inhibit cell 
proliferation by regulating cyclin-dependent kinase 
1 (CDK1) and cyclin B, markers of the transition 
from G2 to M phases, and through regulating tumor 
suppressor gene that plays an important role in 
holding the cell cycle, p53 in breast cancer cells 
MCF-7 and HeLa cervical cancer cells (Arullappan 
et al., 2017). Further isolation and purification, as 
well as the characterization of pure compounds 
which are potentially needed to lead to more specific 
bioactivity and to obtain maximum test results. 
IV.  Conclusion 
The results of cytotoxicity tests on MCF-7 
cells revealed IC50 values: 493.57 µg / ml, but this 
value obtained > 200 µg / ml revealed that the 
sample activity was very weak. 
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